GHRP-6 FAQ: Your Questions Answered
The questions below are the ones that come up specifically about GHRP-6, rather than general peptide questions that apply to everything.
In plain English
Common questions: why it needs such strict darkness, what the mirror-image amino acids do, how it led to the discovery of ghrelin, and why Ipamorelin largely replaced it in research.
What GHRP-6 actually is
GHRP-6 is a six-amino-acid molecule from the 1980s that triggers growth hormone release. It has a genuinely remarkable history: it was built and shown to work years before anyone identified the receptor it acted on, and the hunt for that receptor eventually led researchers to discover ghrelin in 1999.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
GHRP-6 — common questions
Why does GHRP-6 need such strict light protection?
It contains two tryptophan residues. Tryptophan is the most photo-labile of the proteinogenic amino acids, and having two of them means twice the number of sites at which light-driven oxidation can occur. Visible yellowing of the material is the same reaction becoming apparent to the eye.
What do the D-amino acids in GHRP-6 do?
D-Trp at position 2 and D-Phe at position 5 resist proteases, which recognise L-configured backbones. This substantially extends the peptide's survival in biological media. It does nothing at all for photo-stability, which is a purely chemical vulnerability — a useful reminder that "stable" always needs a qualifier.
How is GHRP-6 related to ghrelin's discovery?
Directly. GHRP-6 was synthesised in the 1980s and clearly worked, but acted on an unidentified receptor. That receptor was cloned in 1996 and named the growth hormone secretagogue receptor; the hunt for its natural ligand ended in 1999 with the identification of ghrelin. The synthetic compound led researchers to a previously unknown hormone.
Why did Ipamorelin largely replace GHRP-6 in research?
Selectivity. GHRP-6 stimulates cortisol and prolactin alongside GH, which confounds experimental interpretation. Ipamorelin was designed to retain the GH effect without those, giving cleaner data in study designs where GH is the variable of interest.
What GHRP-6 is studied for
Acts at GHS-R1a — the receptor whose search for an endogenous ligand led to ghrelin's discovery.
Strong GH-releasing activity in research models, historically the compound's defining property.
Ghrelin-receptor activity links it to appetite pathways in metabolic research models.
A landmark in reverse pharmacology: the synthetic ligand preceded knowledge of both receptor and natural ligand.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More GHRP-6 reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
FAQ reference for other compounds
GHRP-6 is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.